She gives the example of Theraflu, a brand designed to give relief from cold and flu symptoms. The brand’s purpose is to “fight for a flu safe world”. One of the ways of doing this, she says, is to ...
The new company -- owning brands including Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu -- is set for a valuation of about ?40 billion ($47.4 billion) when it begins ...
The new company -- which owns brands including Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu -- was worth lower than an expected £40 billion, with its shares down ...
Haleon, which makes Panadol painkillers and Theraflu and Contac cold medicines, said the boost was “supported by the Covid-19 Omicron wave underpinning results across all regions”. Revenues ...
CEO Brian McNamara said a stronger demand in cold and flu medicines, such as the firm’s Panadol, Theraflu, and Advil products, had buoyed revenue despite the up to £200m it took for Haleon to ...
MSN17d
The new independent company -- which owns brands including Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu -- was worth around £30 billion ($36 billion). It was the ...
Its full results for the first half of 2022 will be published in September but H1 organic revenue grew by about 11.6%, boosted as demand for brands such as Panadol, Theraflu, Otrivin and Advil ...
Haleon is not aware of any material developments in relation to the Zantac litigation since the Haleon prospectus was issued on 1 June 2022. · Haleon is not a party to any of the Zantac claims. · ...
Haleon is a global leading company in the consumer healthcare markets of 170 countries, selling numerous well-known brands such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin ...
The new company -- owning brands including Sensodyne toothpaste, pain relief drug Panadol and cold treatment Theraflu -- is set for a valuation of about £40 billion ($47.4 billion) when it begins ...